出典: meddic

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2016/07/09 18:44:39」(JST)

wiki en

[Wiki en表示]

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.


  • The role of cystatin C as a biomarker for prognosis in pulmonary arterial hypertension due to congenital heart disease.
  • Blok IM1, van Riel AC1, Schuuring MJ2, de Bruin-Bon RH2, van Dijk AP3, Hoendermis ES4, Zwinderman AH2, Mulder BJ1, Bouma BJ5.
  • International journal of cardiology.Int J Cardiol.2016 Apr 15;209:242-7. doi: 10.1016/j.ijcard.2016.02.003. Epub 2016 Feb 6.
  • BACKGROUND: Adults with pulmonary arterial hypertension due to congenital heart disease (PAH-CHD) have a poor prognosis. Identifying patients with a high risk for clinical events and death is important because their prognosis can be improved by intensifying their treatment. Cystatin C, a novel cardi
  • PMID 26897077
  • [Changes in the prognosis and treatment of Waldenström macroglobulinemia. Literature overview and own experience].
  • Adam Z, Pour L, Krejčí M, Ševčíková S, Pourová E, Ševčíková E, Král Z, Mayer J.
  • Vnitr̆ní lékar̆ství.Vnitr Lek.2016 Spring;62(1):25-39.
  • Waldenström macroglobulinemia is defined by the presence of monoclonal immunoglobulin IgM type (M-IgM) and evidence of lymphoplasmacytic bone marrow infiltration. The disease has an indolent course, the treatment is only initiated when the disease has begun to damage its carrier. The following symp
  • PMID 26967234
  • Prevalence of thrombophilic disorders in takotsubo patients: the (ThROmbophylia in TAkotsubo cardiomyopathy) TROTA study.
  • Cecchi E1, Parodi G2, Fatucchi S2, Angelotti P2, Giglioli C2, Gori AM3,4, Bandinelli B3, Bellandi B2, Sticchi E3, Romagnuolo I3, Mannini L2, Antoniucci D2, Abbate R3.
  • Clinical research in cardiology : official journal of the German Cardiac Society.Clin Res Cardiol.2016 Mar 22. [Epub ahead of print]
  • Takotsubo cardiomyopathy (TTC) pathophysiology is still unclear. A transient intracoronary thrombosis dissolved at the time of angiography has been hypothesized. We aimed to evaluate the prevalence of thrombophilic disorders in TTC patients. In 75 TTC women, 75 age- and sex-matched acute coronary sy
  • PMID 27003690


  • 症例 腫瘤性および間質性肺病変を呈し,高Ca血症を伴った原発性マクログロブリン血症の1例
  • 山根 宏美,柏原 光介,田中 秀幸
  • 日本呼吸器学会誌 = Annals of the Japanese Respiratory Society 3(1), 111-115, 2014-01-10
  • NAID 40019962384
  • Antivasospastic Effects of Hydroxyfasudil, a Rho-Kinase Inhibitor, After Subarachnoid Hemorrhage
  • Satoh Shin-ichi,Takayasu Masakazu,Kawasaki Koh [他],IKEGAKI Ichiro,HITOMI Asako,YANO Kazuo,SHIBUYA Masato,ASANO Toshio
  • Journal of pharmacological sciences 118(1), 92-98, 2012-01-20
  • … The results also suggest that hydroxyfasudil contributes to the potency of fasudil to prevent cerebral vasospasm and hyperviscosity and suggest the potential utility of hydroxyfasudil as a therapeutic agent for patients with SAH. …
  • NAID 10030454320
  • ネフローゼ症候群における血栓合併症
  • 井庭 慶典,杉本 圭相,柳田 英彦,岡田 満,竹村 司
  • Nihon Shoni Jinzobyo Gakkai Zasshi 24(1), 54-59, 2011
  •  血栓発症の背景にはさまざまな基礎疾患が存在し,さらに動脈血栓と静脈血栓ではその基礎疾患や発症病態も異なる。臨床的には単一因子ではなく,多くのリスク因子が混在し血栓が発症すると考えられる。ネフローゼ症候群は血栓形成の基礎疾患として重要であり,合併症として静脈血栓症はよく知られており,その発症には血液粘稠度の亢進に加え,凝固阻止因子の低下が発症の原因と考えられている。今回,ネフローゼ症候群の再発時に …
  • NAID 130001353977


Hyperviscosity syndrome (HVS) refers to the clinical sequelae of increased blood viscosity. Increased serum viscosity usually results from increased circulating serum immunoglobulins and can be seen in such diseases ...
The outlook is good for infants with mild hyperviscosity. Good results are also possible in infants who receive treatment for severe hyperviscosity. The outlook will depend largely on the reason for the condition. Some children may have ...